Bt354 as a new STAT3 signaling pathway inhibitor against triple negative breast cancer

• Yue Chen, Ming Ji, Shen Zhang, Nina Xue, Heng Xu, Songwen Lin, Xiaoguang Chen

• Journal of Drug Targeting, April 2018, Taylor & Francis
• DOI: 10.1080/1061186x.2018.1452244